Antiviral treatment of genital herpes

International Journal of STD and AIDS

Volumn 15, Issue 7, 2004, Pages 429-433

  Apoola, A ^a   Radcliffe, K ^a  

^a Whittall Street Clinic ^*  (United Kingdom)

Author keywords

Aciclovir; Famciclovir; Genital herpes infection; Treatment; Valaciclovir

Indexed keywords

ACICLOVIR; ANTIVIRUS AGENT; FAMCICLOVIR; PLACEBO; VALACICLOVIR;

CLINICAL TRIAL; DOSE RESPONSE; DRUG COST; DRUG EFFECT; DRUG EFFICACY; DRUG TOLERABILITY; DRUG TOXICITY; GENITAL HERPES; HERPES SIMPLEX VIRUS; HUMAN; PRIORITY JOURNAL; RANDOMIZATION; REVIEW; SYMPTOMATOLOGY; VIRUS SHEDDING;

2-AMINOPURINE; ACYCLOVIR; ADMINISTRATION, ORAL; ANTIVIRAL AGENTS; HERPES GENITALIS; HUMANS; RANDOMIZED CONTROLLED TRIALS; RECURRENCE; VALINE;

EID: 3242727641     PISSN: 09564624     EISSN: None     Source Type: Journal    
DOI: 10.1258/0956462041211153     Document Type: Review

References (35)

1. Bryson YJ, Dillon M, Lovett M, et al. Treatment of first episodes of genital herpes simplex virus infection with oral acyclovir. A randomized double-blind controlled trial in normal subjects. N Engl J Med 1983;308:916-21
2. Mertz GJ, Critchlow CW, Benedetti J, et al. Double-blind placebo-controlled trial of oral acyclovir in first-episode genital herpes simplex virus infection. JAMA 1984;252: 1147-51
3. Nilsen AE, Aasen T, Halsos AM, et al. Efficacy of oral acyclovir in the treatment of initial and recurrent genital herpes. Lancet 1982;ii:571-3
4. Rompalo AM, Mertz GJ, Davis LG, et al. Oral acyclovir for treatment of first-episode herpes simplex virus proctitis. JAMA 1988;259:2879-81
5. Mindel A, Adler MW, Sutherland S, Fiddian AP. Intravenous acyclovir treatment for primary genital herpes. Lancet 1982;i:697-700
6. Peacock JE Jr, Kaplowitz LG, Sparling PF, et al. Intravenous acyclovir therapy of first episodes of genital herpes: a multicenter double-blind, placebo-controlled trial. Am J Med 1988;85:301-6
7. Corey L, Fife KH, Benedetti JK, et al. Intravenous acyclovir for the treatment of primary genital herpes. Annn Intern Med 1983;98:914-21
8. Corey L, Nahmias AJ, Guinan ME, Benedetti JK, Critchlow CW, Holmes KK. A trial of topical acyclovir in genital herpes simplex virus infections. N Engl J Med 1982;306: 1313-19
9. Kinghorn GR, Turner EB, Barton IG, Potter CW, Burke CA, Fiddian AP. Efficacy of topical acyclovir cream in first and recurrent episodes of genital herpes. Antiviral Res 1983;3:291-301
10. Thin RN, Nabarro JM, Parker JD, Fiddian AP. Topical acyclovir in the treatment of initial genital herpes. Br J Vener Dis 1983;59:116-19
11. Fife KH, Barbarash RA, Rudolph T, Degregorio B, Roth R. Valaciclovir versus acyclovir in the treatment of first-episode genital herpes infection. Results of an international, multicenter, double-blind, randomized clinical trial. The Valaciclovir International Herpes Simplex Virus Study Group. Sex Transm Dis 1997;24:481-6
12. Loveless MO, Harris W, Sacks SL. Treatment of first episode genital herpes with famciclovir. 35th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, USA, 1995: Abstract H12
13. Kinghorn GR. Topical acyclovir in the treatment of recurrent herpes simplex virus infections. Scand J Infect Dis 1985;47(Suppl):58-62
14. Corey L, Benedetti JK, Critchlow CW, et al. Double-blind controlled trial of topical acyclovir in genital herpes simplex virus infections. Am J Med 1982;73(1A):326-34
15. Dorsky DI, Crumpacker CS. Drugs five years later: acyclovir. Ann Intern Med 1987;107:859-74
16. Bryson Y, Dillon M, Lovett M, Bernstein D, Garratty E, Sayre J. Treatment of first episode genital HSV with oral acyclovir: long term follow-up of recurrences. A preliminary report. Scand J Infect Dis 1985;47(Suppl):70-5
17. Corey L, Mindel A, Fife KH, Sutherland S, Benedetti J, Adler MW. Risk of recurrence after treatment of first-episode genital herpes with intravenous acyclovir. Sex Transm Dis 1985;12:215-18
18. Reichman RC, Badger GJ, Mertz GJ, et al. Treatment of recurrent genital herpes simplex infections with oral acyclovir. A controlled trial. JAMA 1984;251:2103-7
19. Tyring SK, Douglas JM Jr, Corey L, Spruance SL, Esmann J. A randomized, placebo-controlled comparison of oral valacyclovir and acyclovir in immunocompetent patients with recurrent genital herpes infections. The Valaciclovir International Study Group. Arch Dermatol 1998;134:185-91
20. Spruance SL, Tyring SK, Degregorio B, Miller C, Beutner K. A large-scale, placebo-controlled, dose-ranging trial of peroral valaciclovir for episodic treatment of recurrent herpes genitalis. Valaciclovir HSV Study Group. Arch Intern Med 1996;156:1729-35
21. Sacks SL, Aoki FY, Diaz-Mitoma F, Sellors J, Shafran SD. Patient-initiated, twice-daily oral famciclovir for early recurrent genital herpes. A randomized, double-blind multicenter trial. Canadian Famciclovir Study Group. JAMA 1996;276:44-9
22. Chosidow O, Drouault Y, Leconte-Veyriac F, et al. Famciclovir vs. aciclovir in immunocompetent patients with recurrent genital herpes infections: a parallel-groups, randomized, double-blind clinical trial. Br J Dermatol 2001;144:818-24
23. Leone PA, Trottier S, Miller JM. Valacyclovir for episodic treatment of genital herpes: a shorter 3-day treatment course compared with 5-day treatment. Clin Infect Dis 2002;34:958-62
24. Wald A, Carrell D, Remington M, Kexel E, Zeh J, Corey L. Two-day regimen of acyclovir for treatment of recurrent genital herpes simplex virus type 2 infection. Clin Infect Dis 2002;34:944-8
25. Bodsworth NJ, Crooks RJ, Borelli S, et al. Valaciclovir versus aciclovir in patient initiated treatment of recurrent genital herpes: a randomized, double blind clinical trial. International Valaciclovir HSV Study Group. Genitourin Med 1997;73:110-16
26. Strand A, Patel R, Wulf HC, Coates KM. Aborted genital herpes simplex virus lesions: findings from a randomized controlled trial with valaciclovir. Sex Transm Infect 2002;78:435
27. Mindel A, Faherty A, Carney O, Patou G, Freris M, Williams P. Dosage and safety of long-term suppressive acyclovir therapy for recurrent genital herpes. Lancet 1988;i:926-8
28. Mattison HR, Reichman RC, Benedetti J, et al. Double-blind, placebo-controlled trial comparing long-term suppressive with short-term oral acyclovir therapy for management of recurrent genital herpes. Am J Med 1988;85:20-5
29. Mertz GJ, Jones CC, Mills J, et al. Long-term acyclovir suppression of frequently recurring genital herpes simplex virus infection. A multicenter double-blind trial. JAMA 1988;260:201-6
30. Fife KH, Crumpacker CS, Mertz GJ, Hill EL, Boone GS. Recurrence and resistance patterns of herpes simplex virus following cessation of > or =6 years of chronic suppression with acyclovir. Acyclovir Study Group. J Infect Dis 1994;169:1338-41
31. Goldberg LH, Kaufman R, Kurtz TO, et al. Long-term suppression of recurrent genital herpes with acyclovir. A 5-year benchmark. Acyclovir Study Group. Arch Dermatol 1993;129:582-7
32. Mertz GJ, Loveless MO, Levin MJ, et al. Oral famciclovir for suppression of recurrent genital herpes simplex virus infection in women. A multicenter, double-blind, placebo-controlled trial. Collaborative Famciclovir Genital Herpes Research Group. Arch Intern Med 1997;157:343-9
33. Patel R, Bodsworth NJ, Woolley P, et al. Valaciclovir for the suppression of recurrent genital HSV infection: a placebo controlled study of once daily therapy. International Valaciclovir HSV Study Group. Genitourin Med 1997;73:105-9
34. Reitano M, Tyring S, Lang W, Thoming C, Worm AM, Borelli S, et al. Valaciclovir for the suppression of recurrent genital herpes simplex virus infection: a large-scale dose range-finding study. International Valaciclovir HSV Study Group. J Infect Dis 1998;178:603-10
35. Corey L, Tyring S, Beutner K. Once daily valaciclovir reduces transmission of genital herpes. Program and abstracts of the 42nd Annual Interscience Conference on Antimicrobial Agents and Chemotherapy 2003; Abstract LB-3